Association of Epstein-Barr virus antibody titers with a human IL-10 promoter polymorphism in Japanese women

Journal of Autoimmune Diseases

Volumn 5, Issue , 2008, Pages

  Yasui, Yutaka ^a   Hamajima, Nobuyuki ^b   Nakamura, Tsuneya ^c   El Din, Noha Sharaf ^a   Tajima, Kazuo ^c   Potter, John D ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; VIRUS CAPSID ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEALTH SURVEY; HUMAN; JAPANESE; MALE; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 41949113788     PISSN: None     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-5-2     Document Type: Article

References (39)

1. Interleukin-10 and the interleukin-10 receptor. KW Moore R de Waal Malefyt RL Coffman A O'Garra, Annu Rev Immunol 2001 19 683 765 10.1146/annurev.immunol.19.1.683 11244051
2. Multiple sclerosis in the Japanese population. J Kira, Lancet Neurol 2003 2 2 117 27 10.1016/S1474-4422(03)00308-9 12849268
3. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. DL Jacobson SJ Gange NR Rose NM Graham, Clin Immunol Immunopathol 1997 84 3 223 43 10.1006/clin.1997.4412 9281381
4. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. CC Mok JS Lanchbury DW Chan CS Lau, Arthritis Rheum 1998 41 1090 5 10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0. CO;2-6 9627019
5. Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early-onset periodontitis. K Yamazaki K Tabeta T Nakajima Y Ohsawa K Ueki H Itoh H Yoshie, J Clin Periodontol 2001 28 9 828 32 10.1034/j.1600-051x.2001. 028009828.x 11493351
6. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. S Miyazoe K Hamasaki K Nakata Y Kajiya K Kitajima K Nakao M Daikoku H Yatsuhashi M Koga M Yano K Eguchi, Am J Gastroenterol 2002 97 8 2086 92 10.1111/j.1572-0241.2002. 05926.x 12190181
7. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. A Meenagh F Williams OA Ross C Patterson C Gorodezky M Hammond WA Leheny D Middleton, Hum Immunol 2002 63 11 1055 61 10.1016/S0198-8859(02)00440-8 12392859
8. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. MP Reynard D Turner CV Navarrete, Eur J Immunogenet 2000 27 4 241 9 10.1046/j.1365-2370.2000.00227.x 10998089
9. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. J Hulkkonen M Pertovaara J Antonen N Lahdenpohja A Pasternack M Hurme, Arthritis Rheum 2001 44 1 176 9 10.1002/1529-0131(200101) 44:1<176::AID-ANR23>3.0.CO;2-K 11212157
10. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. W Koch A Kastrati C Bottiger J Mehilli N von Beckerath A Schomig, Atherosclerosis 2001 159 1 137 44 10.1016/S0021-9150(01)00467-1 11689215
11. Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFalpha and TNFbeta genes. LH Tseng PJ Chen MT Lin K Singleton EG Martin AH Yen SM Chuang PJ Martin JA Hansen, Tissue Antigens 2002 59 4 280 6 10.1034/j.1399-0039.2002.590405.x 12135426
12. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. MO Moraes AR Santos JJ Schonkeren PR Vanderborght TH Ottenhoff ME Moraes JR Moraes EP Sampaio EN Sarno TW Huizinga, Immunogenetics 2003 54 12 896 9 12671741
13. Epstein-Barr virus antibodies in multiple sclerosis. CV Sumaya LW Myers GW Ellison, Arch Neurol 1980 37 2 94 6 6243930
14. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. PF Bray LC Bloomer VC Salmon MH Bagley PD Larsen, Arch Neurol 1983 40 7 406 8 6860175
15. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. PD Larsen LC Bloomer PF Bray, Neurology 1985 35 3 435 8 2983262
16. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. CV Sumaya LW Myers GW Ellison Y Ench, Ann Neurol 1985 17 4 371 7 10.1002/ana.410170412 2988410
17. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. PV Shirodaria M Haire E Fleming JD Merrett SA Hawkins SD Roberts, Arch Neurol 1987 44 12 1237 41 2823754
18. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. A Ascherio KL Munger ET Lennette D Spiegelman MA Hernan MJ Olek SE Hankinson DJ Hunter, JAMA 2001 286 24 3083 8 10.1001/jama.286.24.3083 11754673
19. Temporal relationship between elevation of epsteinbarr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. LI Levin KL Munger MV Rubertone CA Peck ET Lennette D Spiegelman A Ascherio, JAMA 2005 293 20 2496 500 10.1001/jama.293.20.2496 15914750
20. Epstein-Barr virus and multiple sclerosis. JD Lünemann C Münz, Curr Neurol Neurosci Rep 2007 7 3 253 8 10.1007/s11910-007-0038-y 17488592
21. Immunology of multiple sclerosis. MP Pender JM Greer, Curr Allergy Asthma Rep 2007 7 4 285 92 10.1007/s11882-007-0043-x 17547851
22. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. P Sundstrom P Juto G Wadell G Hallmans A Svenningsson L Nystrom J Dillner L Forsgren, Neurology 2004 62 12 2277 82 15210894
23. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. N Hamajima T Saitoh K Matsuo Ki Kozaki T Takahashi K Tajima, Jpn J Cancer Res 2000 91 865 8 11011111
24. Immunofluorescence in cells derived from Burkitt's lymphoma. G Henle W Henle, J Bacteriol 1966 91 1248 56 4160230
25. Statistical Models in Epidemiology. D Clayton M Hills, New York: Oxford University Press 1993
26. Test for Trend in Proportions. BH Margolin, Encyclopedia of Statistical Sciences New York: John Wiley & Sons, Inc, Klotz S, Johnson NL, 1988 9 334 336
27. Gonadal steroids and immunity. NJ Olsen WJ Kovacs, Endocr Rev 1996 17 4 369 84 10.1210/er.17.4.369 8854050
28. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. BF Bebo Jr E Zelinka-Vincent G Adamus D Amundson AA Vandenbark H Offner, J Neuroimmunol 1998 84 2 122 30 10.1016/S0165-5728(97)00214-2 9628453
29. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. M Dalal S Kim RR Voskuhl, J Immunol 1997 159 1 3 6 9200430
30. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. B He C Xu B Yang AM Landtblom S Fredrikson J Hillert, J Neuroimmunol 1998 86 1 13 9 10.1016/S0165-5728(98)00003-4 9655468
31. Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis. C Pickard C Mann P Sinnott M Boggild C Hawkins RC Strange V Hutchinson WE Ollier RP Donn, J Neuroimmunol 1999 101 2 207 10 10.1016/S0165-5728(99)00146-0 10580805
32. Genetic variation at position -1082 of the interleukin 10 (IL10) promoter and the outcome of multiple sclerosis. M Maurer N Kruse R Giess KV Toyka P Rieckmann, J Neuroimmunol 2000 104 1 98 100 10.1016/S0165-5728(99)00256-8 10683520
33. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. GV McDonnell CW Kirk SA Hawkins CA Graham, J Neurol Sci 2000 176 1 4 12 10.1016/S0022-510X(00)00291-4 10865086
34. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients. A Martinez Doncel A Rubio R Arroyo V de las Heras C Martin M Fernandez-Arquero EG de la Concha, J Neuroimmunol 2002 131 1-2 168 72 10.1016/S0165-5728(02)00248-5 12458048
35. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression. L Almeras B Meresse J Seze D De Lefranc S Dubucquoi I Fajardy P Vermersch L Prin, Eur Cytokine Netw 2002 13 2 200 6 12101075
36. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. KM Myhr KS Vagnes TH Maroy JH Aarseth HI Nyland CA Vedeler, J Neurol Sci 2002 202 1-2 93 7 10.1016/S0022-510X(02)00246-0 12220699
37. Promoter polymorphism of IL-10 and severity of multiple sclerosis. M Luomala T Lehtimaki H Huhtala M Ukkonen T Koivula M Hurme I Elovaara, Acta Neurol Scand 2003 108 6 396 400 10.1034/j.1600-0404.2003.00165.x 14616291
38. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. EF Schippers C van 't Veer S van Voorden CA Martina TW Huizinga S le Cessie JT van Dissel, Cytokine 29 5 215 28 2005 Mar 7 10.1016/j.cyto.2004.12.005 15760678
39. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. S Mihailova M Ivanova A Mihaylova L Quin O Mikova E Naumova, J Neuroimmunol 2005 168 1-2 138 43 10.1016/j.jneuroim.2005. 06.020 16183136